what is glp 1 peptide GLP-1 & Does it Affect Weight & Cognition? Current Insights, Advantages and Challenges
Description
Cardoso, P
Tirzepatide is a once-weekly GIP receptor and GLP-1 receptor agonist that combines the actions of both incretins into a single novel molecule
Similarly, Mounjaro is FDA-approved for diabetes, while its twin drug Zepbound is approved for obesity
Patients with complicating conditions, such as heart failure, atherosclerosis, or chronic kidney disease, in addition to sustained high A1C levels
This isn't just a new drug
Gastroparesis: quality of life and health care utilization
